SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000929638-24-000303
Filing Date
2024-01-30
Accepted
2024-01-30 16:18:45
Documents
1
Period of Report
2024-01-26

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 5063
  Complete submission text file 0000929638-24-000303.txt   7906
Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LP (Reporting) CIK: 0001583977 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37348 | Film No.: 24578415

Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Issuer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CORMORANT ASSET MANAGEMENT, LP 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address
Chen Bihua (Reporting) CIK: 0001599214 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37348 | Film No.: 24578413

Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 617-848-3429
Cormorant Global Healthcare Master Fund, LP (Reporting) CIK: 0001618442 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37348 | Film No.: 24578414